The central nervous system (CNS) may be considered as a sanctuary site, protected from systemic chemotherapy by the meninges, the cerebrospinal fluid (CSF) and the blood-brain barrier (BBB). Consequently, parenchymal and CSF exposure of most antineoplastic agents following intravenous (IV) administration is lower than systemic exposure. In this review, we describe the different strategies developed to improve delivery of antineoplastic agents into the brain in primary and metastatic CNS tumors. We observed that several methods, such as BBB disruption (BBBD), intra-arterial (IA) and intracavitary chemotherapy, are not routinely used because of their invasiveness and potentially serious adverse effects. Conversely, intrathecal (IT) chemotherapy has been safely and widely practiced in the treatment of pediatric primary and metastatic tumors, replacing the neurotoxic cranial irradiation for the treatment of childhood lymphoma and acute lymphoblastic leukemia (ALL). IT chemotherapy may be achieved through lumbar puncture (LP) or across the Ommaya intraventricular reservoir, which are both described in this review. Additionally, we overviewed pharmacokinetics and toxic aspects of the main IT antineoplastic drugs employed for primary or metastatic childhood CNS tumors (such as methotrexate, cytosine arabinoside, hydrocortisone), with a concise focus on new and less used IT antineoplastic agents.

Triarico, S., Maurizi, P., Mastrangelo, S., Attina', G., Capozza, M. A., Ruggiero, A., Improving the Brain Delivery of Chemotherapeutic Drugs in Childhood Brain Tumors, <<CANCERS>>, 2019; 11 (6): 824-N/A. [doi:10.3390/cancers11060824] [http://hdl.handle.net/10807/139161]

Improving the Brain Delivery of Chemotherapeutic Drugs in Childhood Brain Tumors

Maurizi, Palma
Secondo
;
Mastrangelo, Stefano;Attina', Giorgio;Capozza, Michele Antonio
Penultimo
;
Ruggiero, Antonio
Ultimo
2019

Abstract

The central nervous system (CNS) may be considered as a sanctuary site, protected from systemic chemotherapy by the meninges, the cerebrospinal fluid (CSF) and the blood-brain barrier (BBB). Consequently, parenchymal and CSF exposure of most antineoplastic agents following intravenous (IV) administration is lower than systemic exposure. In this review, we describe the different strategies developed to improve delivery of antineoplastic agents into the brain in primary and metastatic CNS tumors. We observed that several methods, such as BBB disruption (BBBD), intra-arterial (IA) and intracavitary chemotherapy, are not routinely used because of their invasiveness and potentially serious adverse effects. Conversely, intrathecal (IT) chemotherapy has been safely and widely practiced in the treatment of pediatric primary and metastatic tumors, replacing the neurotoxic cranial irradiation for the treatment of childhood lymphoma and acute lymphoblastic leukemia (ALL). IT chemotherapy may be achieved through lumbar puncture (LP) or across the Ommaya intraventricular reservoir, which are both described in this review. Additionally, we overviewed pharmacokinetics and toxic aspects of the main IT antineoplastic drugs employed for primary or metastatic childhood CNS tumors (such as methotrexate, cytosine arabinoside, hydrocortisone), with a concise focus on new and less used IT antineoplastic agents.
2019
Inglese
Triarico, S., Maurizi, P., Mastrangelo, S., Attina', G., Capozza, M. A., Ruggiero, A., Improving the Brain Delivery of Chemotherapeutic Drugs in Childhood Brain Tumors, <<CANCERS>>, 2019; 11 (6): 824-N/A. [doi:10.3390/cancers11060824] [http://hdl.handle.net/10807/139161]
File in questo prodotto:
File Dimensione Formato  
Ruggiero_et_al-2019 Cancers.pdf

accesso aperto

Descrizione: Articolo
Tipologia file ?: Versione Editoriale (PDF)
Licenza: Creative commons
Dimensione 925.89 kB
Formato Adobe PDF
925.89 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/139161
Citazioni
  • ???jsp.display-item.citation.pmc??? 20
  • Scopus 48
  • ???jsp.display-item.citation.isi??? 35
social impact